AJOB Empirical Bioethics 10 (2):100-112 (2019)
| Authors |
|
| Abstract | This article has no associated abstract. (fix it) |
| Keywords | No keywords specified (fix it) |
| Categories |
No categories specified (categorize this paper) |
| DOI | 10.1080/23294515.2019.1592264 |
| Options |
Mark as duplicate
Export citation
Request removal from index
|
Download options
References found in this work BETA
Post‐Trial Access to Antiretrovirals: Who Owes What to Whom?Joseph Millum - 2011 - Bioethics 25 (3):145-154.
Reasons Why Post-Trial Access to Trial Drugs Should, or Need Not Be Ensured to Research Participants: A Systematic Review.N. Sofaer & D. Strech - 2011 - Public Health Ethics 4 (2):160-184.
‘Fair Benefits’ Accounts of Exploitation Require a Normative Principle of Fairness: Response to Gbadegesin and Wendler, and Emanuel Et Al.Angela Ballantyne - 2008 - Bioethics 22 (4):239–244.
Attitudes Toward Post‐Trial Access to Medical Interventions: A Review of Academic Literature, Legislation, and International Guidelines. [REVIEW]Kori Cook, Jeremy Snyder & John Calvert - 2016 - Developing World Bioethics 16 (2):70-79.
Subjects' Views of Obligations to Ensure Post-Trial Access to Drugs, Care and Information: Qualitative Results From the Experiences of Participants in Clinical Trials (EPIC) Study.N. Sofaer, C. Thiessen, S. D. Goold, J. Ballou, K. A. Getz, G. Koski, R. A. Krueger & J. S. Weissman - 2009 - Journal of Medical Ethics 35 (3):183-188.
View all 8 references / Add more references
Citations of this work BETA
Formulating an Ethics of Pharmaceutical Disinvestment.Jessica Pace, Tracey-Lea Laba, Marie-Paul Nisingizwe & Wendy Lipworth - 2020 - Journal of Bioethical Inquiry 17 (1):75-86.
Similar books and articles
Forthcoming Practical Framework for Ethics Committees and Researchers on Post-Trial Access to the Trial Intervention and Healthcare.Neema Sofaer, Penney Lewis & Hugh Davies - 2014 - Journal of Medical Ethics 40 (4):217-218.
Should Post-Trial Provision of Beneficial Experimental Interventions Be Mandatory in Developing Countries?Z. Zong - 2008 - Journal of Medical Ethics 34 (3):188-192.
Did We Describe What You Meant? Findings and Methodological Discussion of an Empirical Validation Study for a Systematic Review of Reasons.Marcel Mertz, Neema Sofaer & Daniel Strech - 2014 - BMC Medical Ethics 15 (1):69.
Attitudes Toward Post‐Trial Access to Medical Interventions: A Review of Academic Literature, Legislation, and International Guidelines. [REVIEW]Kori Cook, Jeremy Snyder & John Calvert - 2016 - Developing World Bioethics 16 (2):70-79.
Challenges with Participant Reimbursement: Experiences From a Post-Trial Access Study.Kathryn Therese Mngadi, Janet Frohlich, Carl Montague, Jerome Singh, Nelisiwe Nkomonde, Nomzamo Mvandaba, Fanelesibonge Ntombeka, Londiwe Luthuli, Quarraisha Abdool Karim & Leila Mansoor - 2015 - Journal of Medical Ethics 41 (11):909-913.
Care After Research: A Framework for NHS RECs.Neema Sofaer, Penney Lewis & Hugh Davies - 2012 - Health Research Authority.
Traducción de la Disposición 12792/2016 ANMAT: Procedimiento Para la Solicitud de Importación de la Medicación/ Tratamiento /Materiales Para El Acceso Post-Estudio (Selección, Versión 1.0).Mastroleo Ignacio - manuscript
Undue Inducement: A Case Study in CAPRISA 008.Kathryn T. Mngadi, Jerome A. Singh, Leila E. Mansoor & Douglas R. Wassenaar - 2017 - Journal of Medical Ethics 43 (12):824-828.
Ethics of Medical Care and Clinical Research: A Qualitative Study of Principal Investigators in Biomedical HIV Prevention Research.Bridget G. Haire - 2013 - Journal of Medical Ethics 39 (4):231-235.
Mind the Gap: An Empirical Study of Post‐Trial Access in HIV Biomedical Prevention Trials.Bridget Haire & Christopher Jordens - 2015 - Developing World Bioethics 15 (2):85-97.
Subjects' Views of Obligations to Ensure Post-Trial Access to Drugs, Care and Information: Qualitative Results From the Experiences of Participants in Clinical Trials (EPIC) Study.N. Sofaer, C. Thiessen, S. D. Goold, J. Ballou, K. A. Getz, G. Koski, R. A. Krueger & J. S. Weissman - 2009 - Journal of Medical Ethics 35 (3):183-188.
Implementing Post-Trial Access Plans for HIV Prevention Research.Amy Paul, Maria W. Merritt & Jeremy Sugarman - 2018 - Journal of Medical Ethics 44 (5):354-358.
Analytics
Added to PP index
2019-04-18
Total views
15 ( #648,819 of 2,411,744 )
Recent downloads (6 months)
1 ( #539,061 of 2,411,744 )
2019-04-18
Total views
15 ( #648,819 of 2,411,744 )
Recent downloads (6 months)
1 ( #539,061 of 2,411,744 )
How can I increase my downloads?
Downloads
